Jim Cramer: We’re in the Grips of a Struggle
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
MRK
Merck extends AZ offer again over Chinese antitrust issues
[Reuters – UK Focus] – German liquid crystal maker Merck KGaA extended the offer period for its planned takeover of AZ Electronic Materials for a sixth time on Friday as it continues to seek Chinese antitrust approval. The offer … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is […]
Will Merck & Co. Inc Unseat Biotech’s Hottest Drug?
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
FDA Approves Merck’s RAGWITEKâ„¢ (Short Ragweed Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults
[Business Wire] – Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved RAGWITEKâ„¢ Tablet for Sublingual Use . moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
6:00 pm Merck: FDA approves GRASTEK (Timothy Grass Pollen Allergen Extract) tablets as immunotherapy to treat grass pollen-induced allergic rhinitis with or without conjunctivitis in children and adults
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
Amgen’s Conundrum
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
FDA Approves Merck’s GRASTEK® (Timothy Grass Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Grass Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Children and Adults
[Business Wire] – Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved GRASTEK® Tablet for Sublingual Use [2800 Bioequivalent Allergy Units ]. moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to […]
Merck Data Show Potent Rival to Gilead’s Hepatitis C Pill
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
Merck Announces Results from Studies Evaluating Investigational Hepatitis C Treatments, MK-5172 and MK-8742, in Treatment-Naïve Patients with Genotype 1 Infection
[Business Wire] – Merck , known as MSD outside of the United States and Canada, today announced additional data from the ongoing C-WORTHy study, a multi-arm Phase 2 clinical trial evaluating the efficacy and safety of a once-daily, all-oral regimen combi moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck […]
Untaxed U.S. corporate profits held overseas top $2.1 trillion: study
[Reuters] – Foreign profits held overseas by U.S. corporations to avoid taxes at home nearly doubled from 2008 to 2013 to top $2.1 trillion, said a private research firm’s report, prompting a call for reform by the Senate’s top tax law writer. I do think moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to […]
